Loading...
LGVN Longeveron
Loading...
News
Longeveron Says its Lomecel-B Receives FDA Orphan Drug Designation
09:33 AM EST, 12/06/2021 (MT Newswires) -- Longeveron Inc. (LGVN) said Monday the US Food and Drug Administration has granted orphan drug designation for Lomecel-B to treat Hypoplastic Left Heart Syn
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. The post 7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
2 Big Stock Bets That Are Insiders Are Buying Now
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. The post 2 Big Stock Bets That Are Insiders Are Buying Now appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
Sector Update: Health Care Stocks Inch Higher Pre-Bell Monday
09:03 AM EST, 12/06/2021 (MT Newswires) -- Health care stocks were flat to positive in the lead up to Monday's opening bell as the Health Care SPDR (XLV) gained 0.2% and the iShares NASDAQ Biotechnol
Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome
Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Sy
Longeveron granted Orphan Drug Designation by FDA for Lomecel-B
Longeveron announced that the U.S. Food and Drug Administration, FDA, has granted Orphan Drug Designation, ODD, for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome, HLHS, a rare and lif
Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per yearOrphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon
Longeveron Closes Private Placement of Common Stock, Warrants
04:46 PM EST, 12/03/2021 (MT Newswires) -- Longeveron (LGVN) said late Friday it closed a private placement of about 1.2 million common shares sold at $17.50 apiece, raising gross proceeds of about $
Longeveron Inc. Announces Closing of a $20.5 Million Private Placement
MIAMI, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related an
Sector Update: Health Care Stocks Drifting Lower Ahead of Weekend
03:40 PM EST, 12/03/2021 (MT Newswires) -- Health care stocks were lower this afternoon, with the NYSE Health Care Index falling 0.4% while the SPDR Health Care Select Sector ETF (XLV) was down 0.3%.